Published in J Virol on June 01, 1989
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol (1993) 4.19
Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J Virol (1991) 3.62
Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol (1992) 3.06
Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J Virol (1994) 1.61
Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. J Virol (1992) 1.44
A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. J Virol (2010) 1.43
Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation? EMBO J (1990) 1.40
Oligomerization of the hydrophobic heptad repeat of gp41. J Virol (1995) 1.38
A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J Virol (1994) 1.38
Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J Virol (1994) 1.35
HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes. J Virol (2012) 1.35
The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34
Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected. J Virol (2011) 1.27
Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120. J Virol (1993) 1.20
Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol (1995) 1.20
Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression. J Virol (2001) 1.18
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J Virol (2012) 1.09
Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J Virol (1996) 1.07
Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope. J Virol (2015) 0.97
Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors. J Virol (1994) 0.96
Sulfation of the human immunodeficiency virus envelope glycoprotein. J Virol (1992) 0.92
The HIV glycan shield as a target for broadly neutralizing antibodies. FEBS J (2015) 0.92
Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins. J Virol (1993) 0.91
Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Expert Opin Drug Discov (2009) 0.87
Inhibition of murine leukemia virus envelope protein (env) processing by intracellular expression of the env N-terminal heptad repeat region. J Virol (2005) 0.87
Inhibitory effects of polyethers on human immunodeficiency virus replication. Antimicrob Agents Chemother (1992) 0.81
New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A. J Virol (2015) 0.80
Fangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processing. PLoS One (2012) 0.80
Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1. J Virol (1995) 0.78
Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation. J Virol (1991) 0.77
Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents. Viruses (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem (1985) 26.05
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Synthesis and processing of asparagine-linked oligosaccharides. Annu Rev Biochem (1981) 11.44
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science (1985) 8.53
Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol (1985) 7.35
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell (1988) 7.01
Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell (1983) 5.71
Plasma cell immunoglobulin secretion: arrest is accompanied by alterations of the golgi complex. J Exp Med (1977) 4.59
Intracellular transport of secretory and membrane proteins in hepatoma cells infected by vesicular stomatitis virus. Cell (1980) 4.15
O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus. Cell (1983) 3.73
Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A (1987) 3.47
Optimizing hydrolysis of N-linked high-mannose oligosaccharides by endo-beta-N-acetylglucosaminidase H. Anal Biochem (1984) 2.98
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature (1987) 2.72
Plasma cell immunoglobulin M molecules. Their biosynthesis, assembly, and intracellular transport. J Cell Biol (1979) 2.29
Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc Natl Acad Sci U S A (1987) 2.25
Immunocytochemical localization of procollagen and fibronectin in human fibroblasts: effects of the monovalent ionophore, monensin. J Cell Biol (1980) 1.68
Structure and processing of the mouse mammary tumor virus glycoprotein precursor pr73env. J Virol (1980) 1.49
Intracellular transport of lymphoid surface glycoproteins. Role of the Golgi complex. J Mol Biol (1981) 1.34
Incomplete complex oligosaccharides in semliki forest virus envelope proteins arrested within the cell in the presence of monensin. J Mol Biol (1982) 1.32
Detection and characterization of the protein encoded by the v-rel oncogene. Virology (1986) 1.30
Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J Virol (1989) 1.21
A comparison of the substrate specificities of endo-beta-N-acetylglucosaminidases from Streptomyces griseus and Diplococcus Pneumoniae. Biochem Biophys Res Commun (1975) 1.13
Construction of adenovirus expression vectors by site-directed in vivo recombination. J Mol Appl Genet (1982) 1.12
Mechanism of inhibition of vaccinia virus replication in adenovirus-infected HeLa cells. J Virol (1971) 1.01
Monensin inhibits the conversion of proalbumin to serum albumin in cultured rat hepatocytes. Biochem Biophys Res Commun (1982) 0.91
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (1989) 7.90
Structure of replicating simian virus 40 deoxyribonucleic acid molecules. J Virol (1971) 6.74
Origin and direction of simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 6.39
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med (1995) 4.06
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol (1997) 3.64
Intermediate in SV40 DNA chain growth. Nat New Biol (1972) 3.38
Resolutions and identification of the core deoxynucleoproteins of the simian virus 40. Biochem Biophys Res Commun (1973) 2.90
Sequential protein synthesis following vaccinia virus infection. J Virol (1968) 2.89
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med (1990) 2.65
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J Virol (1989) 2.62
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis (1994) 2.60
Inhibition in the joining of DNA intermediates to growing simian virus 40 chains. J Virol (1973) 2.44
JC virus enhancer-promoter active in human brain cells. Science (1984) 2.36
Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication. J Virol (1967) 2.34
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA. Cell (1982) 2.32
Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol Biol Evol (1999) 2.32
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A (2000) 2.20
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood (2000) 2.15
HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet (1999) 2.13
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J Infect Dis (2000) 1.96
Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin Exp Allergy (2007) 1.94
Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription. Mol Cell Biol (1984) 1.94
N-acylated glycerophospholipids and their derivatives. Prog Lipid Res (1990) 1.77
Metabolic properties of early and late vaccinia virus messenger ribonucleic acid. J Virol (1967) 1.70
Specific initiation site for simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 1.66
NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci (2009) 1.65
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda. HIV Med (2007) 1.58
Simian virus 40 guanine-cytosine-rich sequences function as independent transcriptional control elements in vitro. Mol Cell Biol (1984) 1.52
The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol (1991) 1.51
Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol (2000) 1.51
Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160. J Acquir Immune Defic Syndr (1992) 1.49
Expression of protein kinase C isozymes in nonpregnant and pregnant human myometrium. Am J Obstet Gynecol (2000) 1.46
Unwinding of parental strands during simian virus 40 DNA replication. J Virol (1973) 1.43
The SV40 DNA template for transcription of late mRNA in viral nucleoprotein complexes. Cell (1977) 1.42
Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med (1996) 1.41
Characterization of Simian virus 40 DNA component II during viral DNA replication. J Mol Biol (1973) 1.40
Molecular cloning and predicted full-length amino acid sequence of the type I beta isozyme of cGMP-dependent protein kinase from human placenta. Tissue distribution and developmental changes in rat. FEBS Lett (1989) 1.39
Biochemical changes in phytohemagglutinin stimulated human lymphocytes. Exp Cell Res (1966) 1.39
In vitro transcription initiation by purified RNA polymerase II within the adenovirus 2 major late promoter region. J Biol Chem (1984) 1.38
Occurrence and properties of a chromatin-associated F1-histone phosphokinase in mitotic Chinese hamster cells. Biochemistry (1972) 1.38
Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis. J Clin Microbiol (1989) 1.36
The N-acylation-phosphodiesterase pathway and cell signalling. Chem Phys Lipids (1996) 1.35
Superhelix density of replicating simian virus 40 DNA molecules. J Mol Biol (1974) 1.34
Chemical modification of simian virus 40 DNA by reaction with a water-soluble carbodiimide. J Virol (1976) 1.31
Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve. J Neuropathol Exp Neurol (1980) 1.31
Proximal and distal domains that control in vitro transcription of the adenovirus IVa2 gene. Proc Natl Acad Sci U S A (1984) 1.30
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors. Virology (1992) 1.29
Mapping of transcription sites of simian virus 40-specific late 16S and 19S mRNA by electron microscopy. Proc Natl Acad Sci U S A (1977) 1.28
N-Acylethanolamine accumulation in infarcted myocardium. Biochem Biophys Res Commun (1979) 1.27
Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1). Genomics (1997) 1.27
Factors involved in specific transcription by mammalian RNA polymerase II. Role of factors IID and MLTF in transcription from the adenovirus major late and IVa2 promoters. J Biol Chem (1989) 1.26
Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60(src). Am J Physiol (1999) 1.26
Properties of simian virus 40 transcriptional intermediates isolated from nuclei of permissive cells. J Virol (1977) 1.25
Persistence of four related human immunodeficiency virus subtypes during the course of zidovudine therapy: relationship between virion RNA and proviral DNA. J Virol (1994) 1.25
Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal (2007) 1.24
Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J Virol (1989) 1.21
Efficient transcription of a compact nucleoprotein complex isolated from purified simian virus 40 virions. J Virol (1980) 1.21
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nat Med (1998) 1.21
Studies of polyoma virus DNA: cleavage map of the polyoma virus genome. J Virol (1975) 1.20
Characterization of simian virus 40 tsA58 transcriptional intermediates at restrictive temperatures: relationship between DNA replication and transcription. J Virol (1977) 1.20
Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J Biol Chem (1983) 1.20
Regulation of simian virus 40 early and late gene transcription without viral DNA replication. J Virol (1979) 1.14
Separation of isolated Chinese hamster metaphase chromosomes into three size-groups. J Mol Biol (1968) 1.14
Mapping 5' termini of JC virus late RNA. J Virol (1986) 1.13
Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta (1980) 1.12
N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim Biophys Acta (1982) 1.12
F1-histone modification at metaphase in Chinese hamster cells. Exp Cell Res (1972) 1.11
Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro. J Pharmacol Exp Ther (2009) 1.11
Characterization of the 5'-terminal structure of simian virus 40 early mRNA's. J Virol (1979) 1.10
Hin D restriction mapping of upaired regions in simian virus 40 superhelical DNA I: considerations regarding structure-function relationships. J Virol (1976) 1.10
Preferential stimulation of transcription from simian virus 40 late and adeno IVa2 promoters in a HeLa cell extract. J Biol Chem (1983) 1.08
Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation. J Appl Physiol (1985) (2000) 1.07
Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem (1984) 1.05
Late replicative intermediates are accumulated during simian virus 40 DNA replication in vivo and in vitro. J Virol (1979) 1.03
Selective degradation of newly synthesized nonmessenger simian virus 40 transcripts. J Virol (1978) 1.03
Characterization of a surrogate TATA box promoter that regulates in vitro transcription of the simian virus 40 major late gene. Mol Cell Biol (1985) 1.03
Significantly reduced radiation exposure to operators during kyphoplasty and vertebroplasty procedures: methods and techniques. AJNR Am J Neuroradiol (2006) 1.03
Simian virus 40 DNA replication: characterization of gaps in the termination region. J Virol (1976) 1.02
Self-annealing of 4 S strands from replicating simian virus 40 DNA. J Mol Biol (1973) 1.02
Properties of replicating SV40 DNA molecules and mapping unpaired regions in SV40 DNA I. Cold Spring Harb Symp Quant Biol (1975) 1.02
Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol (1999) 1.01
Interferon-alpha produces significant decreases in HIV load. J Interferon Cytokine Res (2010) 0.99
Adenovirus-2 E1a and E1b gene products regulate enhancer mediated transcription. Nucleic Acids Res (1986) 0.99
N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim Biophys Acta (1986) 0.98
Sociological aspects of child labour. Indian J Pediatr (1985) 0.97
The relationship of SV40 replicating chromosomes to two forms of the non-replicating SV40. Nucleic Acids Res (1978) 0.97
Positive and negative control sequences within the distal domain of the adenovirus IVa2 promoter overlap with the major late promoter. J Virol (1985) 0.96
Activation of protein phosphorylation by oxidants in vascular endothelial cells: identification of tyrosine phosphorylation of caveolin. Free Radic Biol Med (1997) 0.96